04/08/2025
This could completely change how America treats obesity — and it starts now!
BREAKING: The Trump administration just announced a 5-year pilot program that could give millions of Americans on Medicare and Medicaid access to GLP-1 weight loss medications like Wegovy and Zepbound.
This could be one of the biggest public health shifts in years.
Here’s what this means, who qualifies, and why it’s a game-changer for obesity treatment in America.
Do you think weight loss medications should be publicly funded? Let’s talk in the comments.
Follow for more updates on healthcare, policy, and breakthrough treatments.